Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Inventory: 2021-2025

Historic Inventory for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Sep 2025 value amounting to $24.0 million.

  • Mirum Pharmaceuticals' Inventory rose 11.24% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year increase of 11.24%. This contributed to the annual value of $22.4 million for FY2024, which is 0.41% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Inventory stood at $24.0 million, which was up 4.71% from $22.9 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Inventory registered a high of $24.0 million during Q3 2025, and its lowest value of $1.5 million during Q4 2021.
  • For the 3-year period, Mirum Pharmaceuticals' Inventory averaged around $19.6 million, with its median value being $22.2 million (2023).
  • Per our database at Business Quant, Mirum Pharmaceuticals' Inventory soared by 318.54% in 2023 and then decreased by 2.95% in 2024.
  • Over the past 5 years, Mirum Pharmaceuticals' Inventory (Quarterly) stood at $1.5 million in 2021, then skyrocketed by 267.81% to $5.6 million in 2022, then surged by 300.93% to $22.3 million in 2023, then increased by 0.41% to $22.4 million in 2024, then rose by 11.24% to $24.0 million in 2025.
  • Its Inventory stands at $24.0 million for Q3 2025, versus $22.9 million for Q2 2025 and $22.4 million for Q1 2025.